T

Tempo Scan Pacific Tbk PT
IDX:TSPC

Watchlist Manager
Tempo Scan Pacific Tbk PT
IDX:TSPC
Watchlist
Price: 2 570 IDR -0.39% Market Closed
Market Cap: 11.6T IDR
Have any thoughts about
Tempo Scan Pacific Tbk PT?
Write Note

Relative Value

The Relative Value of one TSPC stock under the Base Case scenario is 2 381.44 IDR. Compared to the current market price of 2 570 IDR, Tempo Scan Pacific Tbk PT is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TSPC Relative Value
Base Case
2 381.44 IDR
Overvaluation 7%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
3
vs Industry
78
Median 3Y
0.5
Median 5Y
0.5
Industry
2.5
vs History
9
vs Industry
38
Median 3Y
7
Median 5Y
7.2
Industry
21.9
vs History
46
vs Industry
44
Median 3Y
8.5
Median 5Y
7.5
Industry
16.5
vs History
36
vs Industry
30
Median 3Y
13.8
Median 5Y
10.7
Industry
23.6
vs History
3
vs Industry
57
Median 3Y
0.9
Median 5Y
0.9
Industry
2.1
vs History
3
vs Industry
86
Median 3Y
0.4
Median 5Y
0.3
Industry
2.6
vs History
3
vs Industry
79
Median 3Y
1
Median 5Y
1
Industry
5.2
vs History
28
vs Industry
46
Median 3Y
4.3
Median 5Y
3.9
Industry
13.3
vs History
28
vs Industry
44
Median 3Y
4.3
Median 5Y
3.9
Industry
16.6
vs History
41
vs Industry
47
Median 3Y
5.8
Median 5Y
5
Industry
15.6
vs History
42
vs Industry
34
Median 3Y
7.6
Median 5Y
6.6
Industry
19.1
vs History
3
vs Industry
60
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

TSPC Competitors Multiples
Tempo Scan Pacific Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Tempo Scan Pacific Tbk PT
IDX:TSPC
11.6T IDR 0.9 8.9 4.9 4.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average P/E: 29.5
8.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top